Impact of Paxlovid on international normalized ratio among patients on chronic warfarin therapy

Detalles Bibliográficos
Autores principales: Muse, Oluwatoyosi, Patell, Rushad, Lee, Maria, Lech, Tara, Guirguis, Mirna, Dodge, Laura, Zwicker, Jeffrey I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by The American Society of Hematology 2022
Materias:
Letter to Blood
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906278/
https://www.ncbi.nlm.nih.gov/pubmed/36240439
http://dx.doi.org/10.1182/blood.2022017433
_version_ 1784883965383933952
author Muse, Oluwatoyosi
Patell, Rushad
Lee, Maria
Lech, Tara
Guirguis, Mirna
Dodge, Laura
Zwicker, Jeffrey I.
author_facet Muse, Oluwatoyosi
Patell, Rushad
Lee, Maria
Lech, Tara
Guirguis, Mirna
Dodge, Laura
Zwicker, Jeffrey I.
author_sort Muse, Oluwatoyosi
collection PubMed
description
format Online
Article
Text
id pubmed-9906278
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher by The American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-99062782023-02-08 Impact of Paxlovid on international normalized ratio among patients on chronic warfarin therapy Muse, Oluwatoyosi Patell, Rushad Lee, Maria Lech, Tara Guirguis, Mirna Dodge, Laura Zwicker, Jeffrey I. Blood Letter to Blood by The American Society of Hematology 2022-12-22 2022-10-17 /pmc/articles/PMC9906278/ /pubmed/36240439 http://dx.doi.org/10.1182/blood.2022017433 Text en © 2022 by The American Society of Hematology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to Blood
Muse, Oluwatoyosi
Patell, Rushad
Lee, Maria
Lech, Tara
Guirguis, Mirna
Dodge, Laura
Zwicker, Jeffrey I.
Impact of Paxlovid on international normalized ratio among patients on chronic warfarin therapy
title Impact of Paxlovid on international normalized ratio among patients on chronic warfarin therapy
title_full Impact of Paxlovid on international normalized ratio among patients on chronic warfarin therapy
title_fullStr Impact of Paxlovid on international normalized ratio among patients on chronic warfarin therapy
title_full_unstemmed Impact of Paxlovid on international normalized ratio among patients on chronic warfarin therapy
title_short Impact of Paxlovid on international normalized ratio among patients on chronic warfarin therapy
title_sort impact of paxlovid on international normalized ratio among patients on chronic warfarin therapy
topic Letter to Blood
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906278/
https://www.ncbi.nlm.nih.gov/pubmed/36240439
http://dx.doi.org/10.1182/blood.2022017433
work_keys_str_mv AT museoluwatoyosi impactofpaxlovidoninternationalnormalizedratioamongpatientsonchronicwarfarintherapy
AT patellrushad impactofpaxlovidoninternationalnormalizedratioamongpatientsonchronicwarfarintherapy
AT leemaria impactofpaxlovidoninternationalnormalizedratioamongpatientsonchronicwarfarintherapy
AT lechtara impactofpaxlovidoninternationalnormalizedratioamongpatientsonchronicwarfarintherapy
AT guirguismirna impactofpaxlovidoninternationalnormalizedratioamongpatientsonchronicwarfarintherapy
AT dodgelaura impactofpaxlovidoninternationalnormalizedratioamongpatientsonchronicwarfarintherapy
AT zwickerjeffreyi impactofpaxlovidoninternationalnormalizedratioamongpatientsonchronicwarfarintherapy

Ejemplares similares